Ticker > Company >

Evervie Health share price

Evervie Health Ltd.

  51.98 K   51   2 NSE: PVP BSE: 517556 SECTOR: Construction - Real Estate

48.58
-2.55 (-4.99%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 51.5

Today's Low

₹ 48.58

52 Week High

₹ 72.16

52 Week Low

₹ 23.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1265.04 Cr.

Enterprise Value

₹ 1470.55 Cr.

No. of Shares

26.04 Cr.

P/E

83.01

P/B

5.53

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.79

CASH

₹ 0.48 Cr.

DEBT

₹ 205.99 Cr.

Promoter Holding

61.3 %

EPS (TTM)

₹  0.59

Sales Growth

94.78%

ROE

0.34 %

ROCE

9.88%

Profit Growth

118.52 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year94.78%
3 Year-40.96%
5 Year13.43%

Profit Growth

1 Year118.52%
3 Year-73.29%
5 Year15.43%

ROE%

1 Year0.34%
3 Year5.13%
5 Year-21.1%

ROCE %

1 Year9.88%
3 Year7.85%
5 Year-7.89%

Debt/Equity

0.9633

Price to Cash Flow

619

Interest Cover Ratio

1.0331

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 61.30 0.00
Mar 2026 61.30 0.00
Dec 2025 61.30 0.00
Sep 2025 61.30 0.00
Jun 2025 61.34 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The Company has been maintaining an effective average operating margins of 35.7693503969397% in the last 5 years.
  • Company’s PEG ratio is 0.700273009202237.
  • The company has a high promoter holding of 61.3%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 6.82175258625793.

 Limitations

  • The company has shown a poor profit growth of -73.2937096990268% for the Past 3 years.
  • The company has shown a poor revenue growth of -40.9624505778914% for the Past 3 years.
  • Company has a poor ROE of 5.12993333333333% over the past 3 years.
  • The company is trading at a high PE of 83.01.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 9.19 5.07 8.04 10.62 13.49
Total Expenditure 4.4 5.7 3.78 2.94 3.93
Operating Profit 4.79 -0.63 4.26 7.68 9.56
Other Income 3.57 3.6 2.92 10.41 25.43
Interest 8.06 8.16 7.23 8.1 8.9
Depreciation 0.14 0.14 0.14 0.53 0.28
Exceptional Items 0 0 0 -3.06 -10.85
Profit Before Tax 0.15 -5.33 -0.19 6.41 14.96
Tax -0.63 -1.35 2 0.13 -0.15
Profit After Tax 0.78 -3.98 -2.18 6.28 15.11
Adjusted EPS (Rs) 0.03 -0.15 -0.08 0.24 0.58

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 32.21 160 0 16.9 32.92
Total Expenditure 7.96 20.71 10.75 22.42 16.74
Operating Profit 24.25 139.29 -10.75 -5.52 16.18
Other Income 0.66 0.14 7.68 11.28 20.49
Interest 28.18 7.62 4.9 3.62 31.63
Depreciation 0.57 0.85 0.8 0.89 0.94
Exceptional Items -498.51 -68.71 36.5 -6.7 -3.06
Profit Before Tax -502.34 62.25 27.72 -5.45 1.05
Provision for Tax 0 24.28 -4.68 -1.54 0.32
Net Profit -502.34 37.97 32.39 -3.9 0.72
Adjusted EPS (Rs.) -20.5 1.55 1.24 -0.15 0.03

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 245.05 245.05 260.4 260.4 260.4
Total Reserves -164.14 -76.09 -45.72 -50.46 -46.57
Borrowings 52.1 0 1.39 1.08 129.78
Other N/C liabilities -0.79 65.85 76.02 104.42 81.27
Current liabilities 269.09 58.84 54.36 48.33 89.51
Total Liabilities 401.31 293.66 346.46 363.77 514.4
Assets
Net Block 2.45 2.66 1.81 2.96 5.09
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 331.85 225.01 26 40.62 179.9
Loans & Advances 1.66 1.61 118.81 128.47 140.93
Other N/C Assets 0.07 0.07 136.92 136.26 138.22
Current Assets 65.28 64.3 62.93 55.46 50.26
Total Assets 401.31 293.66 346.46 363.77 514.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations -502.34 62.25 27.72 -5.45 1.05
Adjustment 525.67 79.05 -38.29 -0.05 15.1
Changes in Assets & Liabilities -23.3 42.67 10.01 42.71 -13.94
Tax Paid 0 -1.62 -0.01 -16.04 -0.17
Operating Cash Flow 0.03 182.36 -0.57 21.18 2.04
Investing Cash Flow -14.88 -84.75 7.64 -19.01 -152.31
Financing Cash Flow 11.36 -96.26 -8.4 -2.04 150.07
Net Cash Flow -3.49 1.35 -1.34 0.13 -0.19

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Evervie Health Stock Price Analysis and Quick Research Report. Is Evervie Health an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Evervie Health. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Evervie Health has a PE ratio of 82.758031442242 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Evervie Health has ROA of 0.1647% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Evervie Health has a Current ratio of 0.5615.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Evervie Health has a ROE of 0.3413%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Evervie Health has a Debt to Equity ratio of 0.9633 which means that the company has low proportion of debt in its capital.

  • Sales growth: Evervie Health has reported revenue growth of 94.7824% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Evervie Health for the current financial year is 49.1533248893627%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Evervie Health is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Evervie Health is Rs 0.5852. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Evervie Health in Ticker for free. Also, one can get the intrinsic value of Evervie Health by using Valuation Calculators, which are available with a Finology ONE subscription. 

Evervie Health FAQs

Q1. What is Evervie Health share price today?
Ans: The current share price of Evervie Health is Rs 48.43.

Q2. What is the market capitalisation of Evervie Health?
Ans: Evervie Health has a market capitalisation of Rs 1261.135027083 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Evervie Health?
Ans: The PE ratio of Evervie Health is 82.758031442242 and the P/B ratio of Evervie Health is 5.50841674249318, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Evervie Health share?
Ans: The 52-week high share price of Evervie Health is Rs 72.04, and the 52-week low share price of Evervie Health is Rs 23.

Q5. Does Evervie Health pay dividends?
Ans: Currently, Evervie Health does not pay dividends. Dividend yield of Evervie Health is around 0%.

Q6. What are the face value and book value of Evervie Health shares?
Ans: The face value of Evervie Health shares is Rs 10, while the book value per share of Evervie Health is around Rs 8.792. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Evervie Health?
Ans: Evervie Health has a total debt of Rs 205.9874 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Evervie Health?
Ans: The ROE of Evervie Health is 0.3413% and ROCE of Evervie Health is 9.8753%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Evervie Health a good buy for the long term?
Ans: The Evervie Health long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Evervie Health undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Evervie Health appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Evervie Health’s financials?
Ans: You can review Evervie Health’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Evervie Health
X